作者
Daniel Modin, Ditte Madsen Andersen, Tor Biering-Sørensen
发表日期
2018/6
来源
Echo Research & Practice
卷号
5
期号
2
页码范围
R65-R75
出版商
BioMed Central
简介
Heart failure (HF) is a threat to public health. Heterogeneities in aetiology and phenotype complicate the diagnosis and management of HF. This is especially true when considering HF with preserved ejection fraction (HFpEF), which makes up 50% of HF cases. Natriuretic peptides may aid in establishing a working diagnosis in patients suspected of HF, but echocardiography remains the optimal choice for diagnosing HF. Echocardiography provides important prognostic information in both HF with reduced ejection fraction (HFrEF) and HFpEF. Traditionally, emphasis has been put on the left ventricular ejection fraction (LVEF). LVEF is useful for both diagnosis and prognosis in HFrEF. However, echocardiography offers more than this single parameter of systolic function, and for optimal risk assessment in HFrEF, an echocardiogram evaluating systolic, diastolic, left atrial and right ventricular function is beneficial. In …
学术搜索中的文章
D Modin, DM Andersen, T Biering-Sørensen - Echo Research & Practice, 2018